Executive Vice President, Chief Business and Strategy Officer
As Executive Vice President, Chief Business and Strategy Officer (CBSO) at AbbVie, Dr. Nicholas Donoghoe leads Business Development, Corporate Strategy, and Business Technology Operations.
Dr. Donoghoe is focused on establishing strategies and external partnerships across the development continuum that will benefit patients and fuel scientific progress. Under his leadership, AbbVie has completed over $20 billion in external innovation deals since 2023. The Corporate Strategy team has also been instrumental in implementing strategies with the aim of maximizing our R&D efforts.
Additionally, he leads global Business Technology Operations, which includes more than 2,000 individuals dedicated to building new internal capabilities that help deliver remarkable therapies more efficiently and effectively, including leveraging digital technology and artificial intelligence (AI) to unlock new opportunities across our business—from drug discovery to commercial applications—and better serve our patients.
Dr. Donoghoe’s distinguished career includes leadership roles across AbbVie’s R&D and Commercial organizations. Prior to his time at AbbVie, he was a partner at McKinsey & Co. He holds an M.D. from Johns Hopkins School of Medicine.
The product-specific site Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals that are not approved in other countries or region. If you are a resident of a country other than those to which the site is directed, please return to AbbVie.com or contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence. The Internet site that you have requested may not be optimized to your screen size. Do you wish to continue to this product-specific site?